ablacon
1. Category : Machine learning
2. Domain : Machine Learning, Therapeutics
3. Founders : Peter Ruppersberg
4. Established : 2015
5. Number of Employees : 4
6. Operating Status : Active
7. Funding status : Early Stage Venture
8. Website : ablacon.com
9. Country : Greater Denver Area, Western US
10. Latest in News: Ablacon Announces Release of New and Improved Ablamap Technology under Existing CE Mark
Ablacon mainly visualizes in real-time what is going on in the heart. Electrographic flow allows treating atrial fibrillation faster, more precisely and more reliable.
Ablacon invested into venture debt facility of $10 million with Western Technology Investment (WTI) and debt is accompanied by a $2 million equity investment in the Company.
The company announced the release of an updated version of its Ablamap technology under the company’s existing CE Mark as the company is a related to Ajax Health-funded and has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation (AF).
The enhanced physician experience and user interface, along with significantly faster processing times leading to improved procedural efficiency.
To create full temporospatial visualizations of organized action potential flow within chaotic conduction of Atrial Fibrillation it uses novle technique called Ablamap.
Prof. Dr. Tamás Szili-Torok, Chief of Electrophysiology at the Department of Cardiology of the Erasmus Center in Rotterdam, Netherlands say that’s extensively to treat patients at my center and am looking forward to the improvements made in this new release of the technology.
The first randomized controlled study with the Ablamap system is FLOW- atrial fibrillation (AF) and will study the safety and efficacy of using the technology to guide treatment in patients with persistent AFib.
Company mainly focuses on machine learning to precisely localize and characterize the sources of AFib and to guide targeted therapy by visualizing the Electrographic Flow within the cardiac chambers. The technology obtained by CE Mark in 2018 and is currently being used in Europe.
